Breakthrough: Israel is Developing Cancer Vaccine

Share

VaxHit could be applied to 90 percent of all known cancers In a breakthrough development, the Israeli company Vaxil BioTherapeutics has formulated a therapeutic cancer vaccine, now in clinical trials at Hadassah University Medical Center